Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) FCF Margin (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed FCF Margin for 3 consecutive years, with 114.71% as the latest value for Q1 2026.

  • Quarterly FCF Margin fell 5683.0% to 114.71% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 133.68% through Jan 2026, up 848.0% year-over-year, with the annual reading at 132.88% for FY2025, 17078.0% up from the prior year.
  • FCF Margin for Q1 2026 was 114.71% at Kestra Medical Technologies, down from 113.49% in the prior quarter.
  • The five-year high for FCF Margin was 57.87% in Q1 2025, with the low at 191.96% in Q3 2024.
  • Average FCF Margin over 3 years is 141.99%, with a median of 145.28% recorded in 2024.
  • The sharpest move saw FCF Margin soared 5196bps in 2025, then plummeted -5683bps in 2026.
  • Over 3 years, FCF Margin stood at 152.98% in 2024, then grew by 26bps to 113.49% in 2025, then fell by -1bps to 114.71% in 2026.
  • According to Business Quant data, FCF Margin over the past three periods came in at 114.71%, 113.49%, and 177.79% for Q1 2026, Q4 2025, and Q3 2025 respectively.